CU Cancer Center Study: Young patients with metastatic colorectal cancer at higher risk
September 30, 2013 · Comments Off
AURORA, Colo. – Younger patients with colorectal cancer that has spread to other parts of...
Wait times up 78 percent at VA for colorectal cancer procedures
August 26, 2013 · Comments Off
A study published in the August print issue of the Journal of Oncology Practice shows that from 1998-2008, wait times for colorectal cancer operations at Veterans Administration hospitals increased from 19 to 32 days. But researchers think longer waits may be a reflection of several unmeasured variables including more careful care, staffing, and patient conditions or preferences.
AACR News: XL-184 (Cabozantinib) goes 12-for-12 in colorectal cancer explants
April 8, 2013 · Comments Off
The novel c-MET and VEGFR2 inhibitor, XL-184 (Cabozantinib), resulted in a significant decrease in tumor growth in 12 out of 12 colorectal cancer (CRC) patient-derived explants, with 8 of the explants exhibiting stable disease. The results of this preclinical work are presented at the AACR Annual Meeting 2013.
Study revises colorectal cancer risk down and other cancer risks up for women with Lynch Syndrome
February 26, 2013 · Comments Off
A cooperative study that included the University of Colorado Cancer Center, published in this month's issue of the Journal of the National Cancer Institute, revises the risk of colorectal cancer down but other cancers up for women with Lynch Syndrome who have had endometrial cancer.
A diet of resistant starch helps the body resist colorectal cancer
February 19, 2013 · Comments Off
A University of Colorado Cancer Center review published in this month's issue of the journal Current Opinion in Gastroenterology shows that resistant starch helps the body resist colorectal cancer through mechanisms including killing pre-cancerous cells and reducing inflammation that can otherwise promote cancer.
As colorectal cancer gets more aggressive, treatment with grape seed extract is even more effective
January 16, 2013 · Comments Off
This study shows that many of the same mutations that allow colorectal cancer cells to metastasize and survive traditional therapies make them especially sensitive to treatment with GSE," says Molly Derry, doctoral candidate in the lab of Rajesh Agarwal, PhD, investigator at the CU Cancer Center and professor at the Skaggs School of Pharmacy and Pharmaceutical Sciences.
A recipe for increased colorectal cancer screening rates
August 14, 2012 · Comments Off
Screening for colorectal cancer (CRC) is cost-effective and saves lives by early detection. The ability...
Study conducted at University of Colorado Cancer Center finds sigmoidoscopy reduces colorectal cancer rates
May 22, 2012 · Comments Off
THREE KEY POINTS: 20 year, 154,900-person study shows 26 percent reduction in death due to...
NTRK1: a new oncogene and target in lung cancer
May 22, 2012
American Gastroenterological Association – Funding Opportunity
December 9, 2013 · No comments
alk drug lung cancer amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno biomarkers bladder cancer breast cancer cancer grants cancer research colorado Cancer Survivorship clinical trial colorado cancer benefit colorectal cancer crizotinib CU Cancer Center Dan Theodorescu fred hirsch funding opportunity grant head-and-neck cancer james degregori jennifer richer leukemia lung cancer lung cancer research melanoma metastasis microRNA Monique Spillman Pancreatic cancer paul bunn prostate cancer publications rajesh agarwal ross camidge screening skin cancer Thomas Flaig tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith
New tool developed at the CU Cancer Center helps doctors identify patients at highest risk of mortality --... http://t.co/RG1VMhAfyo
If you were planning to attend either our brain tumor support group at University of Colorado Hospital or our... http://t.co/Wsbl49jxag
New Cancer Center study shows active component of grape seed extract effective against cancer cells. http://t.co/nq2Cfar6an
C3 Magazine: Collaborating to Conquer Cancer Fall edition is here. Read stories about fingerprinting cancer, a... http://t.co/ce9xjCSHBi